Search Results - "Peyrin Biroulet, Laurent"

Review article: faecal calprotectin and histologic remission in ulcerative colitis by D'Amico, Ferdinando, Bonovas, Stefanos, Danese, Silvio, Peyrin‐Biroulet, Laurent

“…Summary Background Histologic healing is emerging as a new therapeutic goal in both routine practice and clinical trials in ulcerative colitis (UC). However,…”
Get full text

Inflammatory bowel disease: estimates from the global burden of disease 2017 study by Piovani, Daniele, Danese, Silvio, Peyrin‐Biroulet, Laurent, Bonovas, Stefanos

“…Summary Background Inflammatory bowel disease (IBD) is a significant health problem in the industrialised world, currently increasing in developing countries…”
Get full text

Histologic Remission: The Ultimate Therapeutic Goal in Ulcerative Colitis? by Peyrin–Biroulet, Laurent, Bressenot, Aude, Kampman, Wendy

“…Ulcerative colitis (UC) is a disease of the mucosal layer, and activity of the disease is assumed to be related to mucosal appearance. Mucosal healing has…”
Get full text

Review article: Externally derived control arms—An opportunity for clinical trials in inflammatory bowel disease? by Honap, Sailish, Peyrin‐Biroulet, Laurent

“…Summary Background One of the greatest challenges in the current IBD clinical trial landscape is, perhaps, the recruitment and retention of eligible…”
Get full text

Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis by Sands, Bruce E, Sandborn, William J, Panaccione, Remo, O’Brien, Christopher D, Zhang, Hongyan, Johanns, Jewel, Adedokun, Omoniyi J, Li, Katherine, Peyrin-Biroulet, Laurent, Van Assche, Gert, Danese, Silvio, Targan, Stephan, Abreu, Maria T, Hisamatsu, Tadakazu, Szapary, Philippe, Marano, Colleen

“…Patients with moderate-to-severe ulcerative colitis were randomly assigned to receive placebo or induction doses of ustekinumab. Patients who had a response to…”
Get full text

Systematic review with meta‐analysis: biologics and risk of infection or cancer in elderly patients with inflammatory bowel disease by Piovani, Daniele, Danese, Silvio, Peyrin‐Biroulet, Laurent, Nikolopoulos, Georgios K., Bonovas, Stefanos

“…Summary Background Uncertainty exists concerning the risk of infection and cancer associated with biologic therapies in elderly patients with inflammatory…”
Get full text

Editorial: risankizumab – ready to break ceilings? author's reply by Fumery, Mathurin, Peyrin‐Biroulet, Laurent

“…LINKED CONTENT This article is linked to Fumery et al papers. To view these articles, visit https://doi.org/10.1111/apt.17358 and…”
Get full text

Editorial: shedding new light on extraintestinal manifestations in inflammatory bowel disease by Guillo, Lucas, Peyrin‐Biroulet, Laurent, Danese, Silvio

“…LINKED CONTENT This article is linked to Falloon et al papers. To view these articles, visit https://doi.org/10.1111/apt.16853 and…”
Get full text

Treat to Target: A Proposed New Paradigm for the Management of Crohn's Disease by Bouguen, Guillaume, Levesque, Barrett G, Feagan, Brian G, Kavanaugh, Arthur, Peyrin–Biroulet, Laurent, Colombel, Jean–Frederic, Hanauer, Stephen B, Sandborn, William J

“…The traditional management of Crohn's disease, which is based on progressive, step-wise treatment intensification with re-evaluation of response according to…”
Get full text

Letter: treatment with subcutaneous CT‐P13 in Crohn’s disease patients with intravenous infliximab failure by Caron, Bénédicte, Fumery, Mathurin, Netter, Patrick, Peyrin‐Biroulet, Laurent

“…LINKED CONTENT This article is linked to Hanzel et al papers. To view these articles, visit https://doi.org/10.1111/apt.16609…”
Get full text

Current, new and future biological agents on the horizon for the treatment of inflammatory bowel diseases by Amiot, Aurelien, Peyrin-Biroulet, Laurent

“…Biological agents for inflammatory bowel diseases (IBD) targeting tumor necrosis factor (TNF) have changed the way to treat IBD refractory to standard…”
Get full text

Review article: Risk of cardiovascular events in patients with inflammatory bowel disease receiving small molecule drugs by Olivera, Pablo A., Lasa, Juan S., Peretto, Giovanni, Zuily, Stephane, Danese, Silvio, Peyrin‐Biroulet, Laurent

“…Summary Background In the context of an ageing inflammatory bowel disease (IBD) population, cardiovascular comorbidities become particularly relevant. Novel…”
Get full text

Bowel ultrasound score is accurate in assessing response to therapy in patients with Crohn’s disease by Allocca, Mariangela, Craviotto, Vincenzo, Dell’Avalle, Cecilia, Furfaro, Federica, Zilli, Alessandra, D’Amico, Ferdinando, Bonovas, Stefanos, Peyrin‐Biroulet, Laurent, Fiorino, Gionata, Danese, Silvio

“…Summary Background We developed a non‐invasive bowel ultrasound score (BUSS) to assess disease activity in Crohn’s disease (CD). BUSS >3.52 is an indicator of…”
Get full text

Comparative accuracy of ferritin, transferrin saturation and soluble transferrin receptor for the diagnosis of iron deficiency in inflammatory bowel disease by Daude, Sébastien, Remen, Thomas, Chateau, Thomas, Danese, Silvio, Gastin, Isabelle, Baumann, Cédric, Gueant, Jean Louis, Peyrin‐Biroulet, Laurent

“…Summary Background The diagnosis of iron deficiency is based on ferritin and transferrin saturation (TfS) in inflammatory bowel disease (IBD) patients, yet…”
Get full text

Review article: Measuring disease severity in inflammatory bowel disease – Beyond treat to target by Swaminathan, Akhilesh, Day, Andrew S., Sparrow, Miles P., Peyrin‐Biroulet, Laurent, Siegel, Corey A., Gearry, Richard B.

“…Summary Background Inflammatory bowel disease (IBD) follows a heterogenous disease course and predicting a patient's prognosis is challenging. There is a wide…”
Get full text

Head-to-head trials in inflammatory bowel disease: past, present and future by Pouillon, Lieven, Travis, Simon, Bossuyt, Peter, Danese, Silvio, Peyrin-Biroulet, Laurent

“…With the increase in the number of novel drugs for inflammatory bowel disease (IBD), comparing therapeutic options or strategies has become a key challenge in…”
Get full text

Ulcerative colitis as a progressive disease: The forgotten evidence by Torres, Joana, Billioud, Vincent, Sachar, David B., Peyrin‐Biroulet, Laurent, Colombel, Jean‐Frédéric

“…In the management of Crohn's disease, earlier aggressive treatment is becoming accepted as a strategy to prevent or retard progression to irreversible bowel…”
Get full text

Systematic review with meta-analysis: Medical therapies for treatment of ulcerative proctitis by Aruljothy, Achuthan, Singh, Siddharth, Narula, Neeraj, Moran, Gordon W, Vuyyuru, Sudheer K, Hogan, Malcolm, Zayadi, Alexa, MacDonald, John K, Caron, Benedicte, Danese, Silvio, Peyrin Biroulet, Laurent, Ma, Christopher, Jairath, Vipul

“…Ulcerative proctitis (UP) is a common highly symptomatic form of ulcerative colitis that can be difficult to treat. To assess the efficacy of medical…”
Get full text

Confounding and bias in observational studies in inflammatory bowel disease: a meta‐epidemiological study by Piovani, Daniele, Pansieri, Claudia, Peyrin‐Biroulet, Laurent, Danese, Silvio, Bonovas, Stefanos

“…Summary Background Observational research concerning inflammatory bowel disease (IBD) is highly susceptible to spurious findings because of confounding and…”
Get full text

Editorial: diagnostic precision of iron deficiency in inflammatory bowel disease. Authors’ reply by Daude, Sébastien, Gastin, Isabelle, Peyrin‐Biroulet, Laurent

“…LINKED CONTENT This article is linked to Daude et al and Detlie and Jahnsen papers. To view these articles, visit https://doi.org/10.1111/apt.15739 and…”
Get full text